Karyopharm Therapeutics CEO & Leadership Team Ratings | Comparably
Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
This company is accepting feedback from verified employees
EMPLOYEE
PARTICIPANTS
90
TOTAL
RATINGS
2628

Karyopharm Therapeutics CEO & Leadership Team Ratings

Richard Paulson and the Karyopharm Therapeutics leadership team are scored an A by 90 employees placing it in the Top 10% of companies sized 201-500 Employees on Comparably. The Leadership score includes details about how employees evaluate their executive team, CEO and manager.

Men have higher ratings for their leadership team compared to Women. the Legal department and the Finance department have the most favorable ratings for their leadership team compared to employees of other ethnicities and the Clinical Operations department.

Based on 672 ratings, the Leadership score of 84/100 combines employee feedback on their CEO (82/100), Manager (85/100), and Executive Team (80/100).

Richard Paulson Karyopharm Therapeutics CEO Rating

Top 5% Compared to other companies of similar size in Boston
A+
82 / 100
Richard Paulson Karyopharm Therapeutics' CEORichard Paulson the CEO of Karyopharm Therapeutics received an average score of 82 from Karyopharm Therapeutics employees.
Female employees at Karyopharm Therapeutics rate the CEO the highest.
Male: 81
Female: 83
The IT department at Karyopharm Therapeutics rate the CEO the highest, while Finance department rates the CEO lowest.
IT: 90
Sales: 84
Other: 84
Medical Affairs/HEOR: 83
HR: 81
Research & Development: 80
Legal: 77
Finance: 74
Caucasian employees at Karyopharm Therapeutics rate the CEO the highest.
Caucasian: 84
Other: 78
Asian or Pacific Islander: 76

Karyopharm Therapeutics Manager Rating

Top 5% Compared to other companies of similar size in Boston
A+
85 / 100
Managers received an average score of 85 from Karyopharm Therapeutics employees.
Male employees at Karyopharm Therapeutics rate their Manager the highest.
Male: 89
Female: 84
The Legal department at Karyopharm Therapeutics rate their Manager the highest, while Medical Affairs/HEOR department rates their Manager lowest.
Legal: 93
IT: 92
HR: 91
Other: 90
Finance: 89
Research & Development: 87
Clinical Operations: 82
Sales: 81
Marketing: 79
Medical Affairs/HEOR: 72
Caucasian employees at Karyopharm Therapeutics rate their Manager the highest.
Caucasian: 89
Asian or Pacific Islander: 77
Other: 77

Karyopharm Therapeutics Executive Team Rating

Top 15% Compared to other companies of similar size in Boston
A-
80 / 100
The Executive team received an average score of 80 from Karyopharm Therapeutics employees.
Male employees at Karyopharm Therapeutics rate the Executive Team the highest.
Male: 81
Female: 79
The Other department at Karyopharm Therapeutics rate the Executive Team the highest, while Clinical Operations department rates the Executive Team lowest.
Other: 89
Legal: 88
HR: 85
Research & Development: 84
Marketing: 81
Finance: 81
IT: 78
Medical Affairs/HEOR: 73
Sales: 70
Clinical Operations: 63
Asian or Pacific Islander employees at Karyopharm Therapeutics rate the Executive Team the highest.
Asian or Pacific Islander: 83
Caucasian: 80
Other: 76
×
Rate your company